Skip to main content
. 2023 Jan 20;13:1029270. doi: 10.3389/fgene.2022.1029270

FIGURE 4.

FIGURE 4

Effect of TMEM60 expression combined with isocitrate dehydrogenase (IDH) status on the survival time of glioma patients. Relationship between TMEM60 expression and IDH status based on (A) TCGA and (B) CGGA. Relationship between TMEM60 expression and the WHO grade in the subgroups of IDH mutants in (C) TCGA and (D) CGGA and the subgroups of IDH wild type in (E) TCGA and (F) CGGA. Relationship between TMEM60 expression and patient survival time in the subgroups of different IDH status in (J) TCGA and (H) CGGA. MT-low: IDH mutant and TMEM60 low expression; MT-High: IDH mutant and TMEM60 High expression; WT-low: IDH wildtype and TMEM60 low expression; WT-High: IDH wildtype and TMEM60 high expression.